Archive for March, 2008Communicating Your Way To A Healthy Heart - Science Daily (press release) (Primary Pulmonary Hypertension News)Monday, March 31st, 2008Communicating Your Way To A Healthy HeartScience Daily (press release) - 21 hours ago… at Temple University, including its use in monitoring hypertension, gestational diabetes, head trauma, and gastrointestinal and pulmonary health. … Read More… Teen awaiting lungs transplantThe Republican - MassLive.com, MA - Mar 25, 2008Tessier, a lifelong city resident who attended Center and White Brook Middle […] Posted in primary pulmonary hypertension | No Comments » Teen awaiting lungs transplant - The Republican - MassLive.com (Primary Pulmonary Hypertension News)Monday, March 31st, 2008Teen awaiting lungs transplantThe Republican - MassLive.com, MA - Mar 25, 2008Tessier, a lifelong city resident who attended Center and White Brook Middle Schools, was diagnosed in 2000 with primary pulmonary hypertension, … Read More… Communicating Your Way To A Healthy HeartScience Daily (press release) - 21 hours ago… at Temple University, including its use in monitoring hypertension, […] Posted in primary pulmonary hypertension | No Comments » Teen awaiting lungs transplant - The Republican - MassLive.com (Primary Pulmonary Hypertension News)Sunday, March 30th, 2008Teen awaiting lungs transplantThe Republican - MassLive.com, MA - Mar 25, 2008Tessier, a lifelong city resident who attended Center and White Brook Middle Schools, was diagnosed in 2000 with primary pulmonary hypertension, … Read More… Communicating Your Way To A Healthy HeartScience Daily (press release) - 37 minutes ago… at Temple University, including its use in monitoring hypertension, […] Posted in primary pulmonary hypertension | No Comments » 3 Stocks That Missed the Mark - Motley Fool (Primary Pulmonary Hypertension News)Sunday, March 30th, 20083 Stocks That Missed the MarkMotley Fool - Mar 24, 2008Encysive's claim to fame is the Thelin treatment for a fatal form of pulmonary hypertension, and the company hopes to sell about $45 million of it in 2008. … Read More… Teen awaiting lungs transplantThe Republican - MassLive.com, MA - Mar 25, 2008Tessier, a lifelong city resident who attended […] Posted in primary pulmonary hypertension | No Comments » Teen awaiting lungs transplant - The Republican - MassLive.com (Primary Pulmonary Hypertension News)Saturday, March 29th, 2008Teen awaiting lungs transplantThe Republican - MassLive.com, MA - Mar 25, 2008Tessier, a lifelong city resident who attended Center and White Brook Middle Schools, was diagnosed in 2000 with primary pulmonary hypertension, … Read More… 3 Stocks That Missed the MarkMotley Fool - Mar 24, 2008Encysive's claim to fame is the Thelin treatment for a fatal form of pulmonary […] Posted in primary pulmonary hypertension | No Comments » 3 Stocks That Missed the Mark - Motley Fool (Primary Pulmonary Hypertension News)Saturday, March 29th, 20083 Stocks That Missed the MarkMotley Fool - Mar 24, 2008Encysive's claim to fame is the Thelin treatment for a fatal form of pulmonary hypertension, and the company hopes to sell about $45 million of it in 2008. … Read More… Teen awaiting lungs transplantThe Republican - MassLive.com, MA - Mar 25, 2008Tessier, a lifelong city resident who attended […] Posted in primary pulmonary hypertension | No Comments » 3 Stocks That Missed the Mark - Motley Fool (Primary Pulmonary Hypertension News)Friday, March 28th, 20083 Stocks That Missed the MarkMotley Fool - Mar 24, 2008Encysive's claim to fame is the Thelin treatment for a fatal form of pulmonary hypertension, and the company hopes to sell about $45 million of it in 2008. … Read More… Teen awaiting lungs transplantThe Republican - MassLive.com, MA - Mar 25, 2008Tessier, a lifelong city resident who attended […] Posted in primary pulmonary hypertension | No Comments » 3 Stocks That Missed the Mark - Motley Fool (Primary Pulmonary Hypertension News)Friday, March 28th, 20083 Stocks That Missed the MarkMotley Fool - Mar 24, 2008Encysive's claim to fame is the Thelin treatment for a fatal form of pulmonary hypertension, and the company hopes to sell about $45 million of it in 2008. … Read More… Posted in primary pulmonary hypertension | No Comments » MannKind Corporation Q4 2007 Earnings Call Transcript - Seeking Alpha (Primary Pulmonary Hypertension News)Thursday, March 27th, 2008MannKind Corporation Q4 2007 Earnings Call TranscriptSeeking Alpha, NY - Mar 24, 2008The other pivotal trial is the 030 trial which is two-year pulmonary safety trial. The primary endpoint to this is change in FCD1. … Read More… 3 Stocks That Missed the MarkMotley Fool - Mar 24, 2008Encysive's claim to fame is the Thelin treatment for a fatal […] Posted in primary pulmonary hypertension | No Comments » 3 Stocks That Missed the Mark - Motley Fool (Primary Pulmonary Hypertension News)Wednesday, March 26th, 20083 Stocks That Missed the MarkMotley Fool - Mar 24, 2008Encysive's claim to fame is the Thelin treatment for a fatal form of pulmonary hypertension, and the company hopes to sell about $45 million of it in 2008. … Read More… MannKind Corporation Q4 2007 Earnings Call TranscriptSeeking Alpha, NY - Mar 24, 2008The other pivotal trial is the […] Posted in primary pulmonary hypertension | No Comments » |
You are currently browsing the primary pulmonary hypertension weblog archives for March, 2008. ArchivesCategoriesMetaRecently Posted
| |
